Temozolomide in metastatic breast cancer (MBC): a phase II trial of the National Cancer Institute of Canada - Clinical Trials Group (NCIC-CTG).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples